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Experimental pyelonephritis: The effect of chronic active pyelo-
neptiritis on renal function. In these experiments, renal function in
chronic active pyelonephritis was investigated and the effect of
antibiotic treatment and elimination of infection on the gross pa-
thology, histopathology and renal function in animals with chronic
pyelonephritis was determined. A severe loss of urine concentrat-
ing capacity was demonstrable when the maximum urinary os-
molality of a group of animals with pyelonephritis was compared
with control animals. Concentrating capacity decreased sharply
over the first month but further loss over an eight-month period
was minimal. A compensatory increase in the glomerular filtration
rate (GFR) in the control, nonchallenged, group occurred after
nephrectomy but no comparable compensation in the infected
group was found. Antibiotic therapy had a marked effect on the
urinary concentrating capacity and the defect in concentrating
ability was significantly less in the treated animals during the first
30 days after challenge. Infection again prevented a compensatory
increase in the GFR of pyelonephritic animals which was not
reversed by antibiotic therapy. Blood urea concentrations in
treated and nontreated animals were not significantly different nor
did the eradication of infection affect the gross pathologic and
histopathologic changes found at autopsy.
Pyélonéphrite expérimentale: Effet de Ia pyélonéphrite chronique
active sur Ia fonction rénale. Dansces experiences Ia fonction rénale
au cours de Ia pyélonéphrite chronique active a été étudiée et l'effet
du traitement antibiotique et de l'élimination de l'infection sur
l'aspect macroscopique, sur l'histologie et sur Ia fonction rénale a
été déterminé chez les animaux atteints de pyelonéphrite chro-
nique. Une perte importante du pouvoir de concentration des
urines est démontrée quand l'osmolalité urinaire maximale du
groupe d'animaux atteints de pyelonéphrite est comparée a celle
des animaux contrôles. Le pouvoir de concentration décroit rapid-
ement pendant le premier mois, mais Ia perte supplémentaire est
minime pendant les huit mois suivants. Une augmentation com-
pensatrice du debit de filtration glomérulaire (GFR) est observée
chez les contrôles après néphrectomie alors qu'aucune com-
pensation comparable n'est obtenue chez les contrôles. Le traite-
ment antibiotique a un effet net sur Ia capacitC de concentrer les
urines et le défaut de concentration est significativement moindre
chez les animaux traités pendant les 30 premiers jours après
l'aggression. Là encore l'infection empêche une augmentation com-
pensatrice de GFR chez les animaux pyélonéphritiques, cette situa-
tion n'est pas transformée par l'antibiothérapie. La concentration
sanguine de l'urée n'est pas significativement différente dans les
deux groupes d'animaux, traités et non traités, de même que
l'éradication de l'infection ne modifie ni l'aspect macroscopique ni
les alterations histologiques a l'autopsie.
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The association of continued renal infection with
chronic progressive pyelonephritis has been accepted
for many years but a number of investigators have
begun to question the validity of this relationship [1—
3].
Most experimental studies have searched for mor-
phologic evidence of progressive lesions during
chronic renal infection but, because of the well recog-
nized difficulties in quantitating histologic changes,
this approach has several limitations. In these experi-
ments we have followed the effect of continuing Es-
cherichia coil renal infection on renal function by
determining the glomerular filtration rate (GFR),
blood urea and urinary concentrating capacity in anti-
biotic-treated and untreated rats with pyelonephritis.
With this protocol it was possible to assess quan-
titatively the degree of renal damage throughout the
course of the disease and finally to compare the re-
sults of functional tests with pathologic details found
at autopsy.
Methods
Induction ofpyelonephritis. Renal infection was pro-
duced by the direct inoculation of E. coil 075 into the
surgically exposed kidney. Details of the procedure
have been given previously [4].
Animal strain. Female rats weighing between 220
and 235 g were obtained from an inbred strain of
hooded rat.
Serum urea. Blood samples were collected at regu-
lar intervals by venipuncture of the dorsal tail vein.
Serum urea analyses were carried out in an autoanaly-
zer (Technicon SMA 12).
Measurement of maximum urine concentrating ca-
pacity. All animals had food and water removed 24 hr
before being placed in a metabolic cage specifically
designed for urine collection. At the end of the 24-hr
period, animals were induced to micturate, using a
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whiff of ether in a nose cone, before being placed in a
metabolic cage still without food or water. All urine
passed overnight was collected in a tube held in an ice
bath. At 9 AM micturition was induced again and this
urine was added to the overnight collection. Urinary
osmolality was measured in an osmometer (Knauer)
after preparing a 1:4 dilution of the urine in distilled
water.
Bacterial content of renal tissue. Nutrient agar pour
plates of serial ten-fold dilutions of homogenized kid-
ney were made to obtain the bacterial count per gram
of wet renal tissue.
Histologic processing. Tissue for histologic exam-
ination was placed directly into a 0.1% solution of
cetylpyridinium chloride in 10% formaldehyde solu-
tion. After routine processing and cutting, sections
were stained with hematoxylin-eosin.
Measurement of GFR. The GFR was measured by
determining the clearance of a single i.v. injection of
51Cr EDTA using the formula proposed by Bryan,
Jarchow and Maher [5]. Full details of the method
have been given [6]. In brief, individual animals were
weighed, anesthetized with ether and 10 iCi of 51Cr
EDTA (Amersham, 100 Ci/ml) injected into the
femoral vein. Sixty minutes later 200 l of blood was
sampled from the tail vein and the time of sampling
noted accurately. Fifty l of the plasma obtained was
counted in a gamma-counter (Echo Electronics).
The clearance of 51Cr-EDTA was calculated from
the following formula:
(Po/Pt)C=VLn _______
t
where C = the clearance in ml/min; V the distribu-
tion volume, determined experimentally and P0, Pt
= the plasma concentration of the isotope at time 0
and time t. Pt is determined from counting a plasma
sample and Po calculated from Po = I/V where I
is the original dose.
Eradication of infection with antibiotic treatment.
Renal infection was eliminated by combined i.m. ther-
apy with gentamicin (20 mg/kg/day) and carbenicil-
un (150 mg/kg/day). Antibiotic therapy was given
for ten days commencing one week after the initiation
of infection and repeated two months later. Gen-
tamicin was administered in the morning and carbeni-
cillin was given in the late afternoon of each day.
Experimental protocol. These investigations were
carried out as two separate experiments to cope with
the logistics of performing renal function analyses on
the number of animals involved. In the first experi-
ment pyelonephritis was established in one group
whose renal function over a 36-week period was com-
pared with an unmanipulated control group. This
experiment established that there were some differen-
ces of interest.
In the second experiment the effect of antibiotic
treatment and the elimination of infection from the
kidney on the preservation of renal function were
determined by comparing the renal function of two
groups of pyelonephritic animals, one of which was
treated with antibiotics.
In all of the experiments, unilaterally nephrecto-
mized animals were used so that the pathologic
changes occurring in the kidney of an animal with
unilateral pyelonephritis would not be masked by
compensatory mechanisms in a contralateral normal
kidney. A control group to determine the effect of
noninfectious renal trauma as a result of the in-
duction procedure for pyelonephritis was not in-
cluded. Preliminary studies established that the gross
and histopathologic renal changes introduced by in-
serting the fine (0.25 mm) capillary into the kidney
and the expulsion of its sterile contents were barely
discernible. In contrast, introduction of viable organ-
isms using the same capillary led to the establishment
of major pyelonephritic lesions which have been illus-
trated in a recent publication [7].
Results
Effect of chronic renal infection on renal function.
Two groups each of 12 rats were unilaterally ne-
phrectomized and pyelonephritis was induced in the
remaining kidney of one group three weeks later. The
other group served as a control. The GFR, blood
urea nitrogen and urinary concentrating capacity
were determined on animals in both groups over a 36-
week period. It was found that GFRs were similar in
the two groups of animals prior to the induction of
pyelonephritis (Fig. 1). A compensatory increase in
the GFR of the control noninfected animals resulted
in a significant difference in the GFR between the two
groups which decreased as the compensatory increase
in the GFR in the control group declined. In contrast
the GFRs in the pyelonephritic animals decreased
during the first six weeks after challenge but during
the latter period of the study they were not signifi-
cantly different from the baseline values.
Blood urea concentrations were also similar in the
control and infected groups prior to infection but a
significant increase in the blood urea in the infected
animals was apparent up to 12 weeks after challenge
(Fig. 2). An inexplicable increase in the blood urea of
two of the control animals reduced the significance of
any changes over the latter period of the study.
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Fig. 1. Glomerular filtration rates in control and pyelonephritic
animals over a 36-week period following the induction of renal in-
fection.
The effect of renal infection on the urinary concen-
trating capacity was also determined and highly sig-
nificant differences were found between the pyelo-
nephritic and control groups (Fig. 3). The loss of
concentrating capacity in the pyelonephritic group
was maximal during the first 6 weeks but a further
slow deterioration of concentrating ability occurred
during the following 30-week period.
Nine months after establishment of infection, both
groups of animals were killed and kidneys removed
for gross, histopathologic and bacteriologic exam-
ination. As was expected there were major differences
between the two groups. Grossly, all the pyelone-
phritic animals showed extensive cortical scarring
whereas kidneys from the control groups were nor-
mal. The degree of damage in the pyelonephritic kid-
neys, assessed by histopathologic examination of se-
rial sections through the kidney, confirmed the gross
appearances. Pathologic changes were most extensive
in the cortex and a marked lymphocytic infiltrate,
focal areas of interstitial fibrosis, tubular dilation and
colloid casts were found in all the kidneys examined.
Glomerular and vascular alterations were minimal
except in scarred areas where glomerular crowding
was commonly seen. Calyceal abnormalities were not
usually present although lesions in the medulla and
papilla were frequently found. Heavy bacterial in-
fection had also persisted in all the pyelonephritic
kidneys whereas the control kidneys were sterile.
Renal function and pathology in antibiotic-treated
and nontreated animals. Forty-two animals were uni-
laterally nephrectomized and pyelonephritis was in-
duced in the remaining kidney of all animals three
weeks later. Seven days after challenge one group of
20 rats was treated with gentamicin and carbenicillin
for 10 days and a similar course of treatment adminis-
tered two months later. This treatment schedule had
been shown previously to be capable of eliminating
infection from the kidney of animals with pyelone-
phritis.
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Fig. 2. Blood urea concentrations in control and pyelonephritic
animals over a 30-week period after the induction of renal infection.
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The GFR and urinary concentrating capacity were
determined in individual animals from both groups
over a period of 36 weeks. Because of the problem of
repeated blood sampling for serum urea estimation,
this index was studied only in ten animals. The GFRs
of both groups were similar before challenge and
P<o.o5 there were no significant differences between the two
groups over the first 12 weeks of the study (Fig. 4).
Although considerable variation in the range of
GFRs was found as time progressed, the GFRs in
some of the untreated animals declined more rapidly
than in the treated groups. Blood urea concentrations
in treated and nontreated pyelonephritic rats were
also compared but no significant differences between
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Fig. 3. Urine concentrating capacity in control and pyelonephritie
animals over a 36-week period after the establishment of renal in-
fection.
the two groups were found over the 36-week period
(Fig. 5). When the urinary concentrating capacities of 0 6 12 26 36the two groups were compared, marked differences
were found (Fig. 6). Six weeks after challenge a Weeks after renal infection
highly significant difference was found between the Fig. 5. Blood urea concentrations in antibiotic-treated and non-
treated pyelonephriizc animals over a 36-week period after challenge.
two groups. A marked reduction in the concentrat-
ing capacity of the pyelonephritic but untreated
group was demonstrated but the concentrating capac- -ity of the treated group of pyeionephritic animals,
although significantly reduced from baseline values,
0 Antibiotic-treated was not affected to the same extent. Over the follow-
a Nontreated ing 30-week interval, however, the concentrating Ca-
pacity of the treated group continued to decline
slowly whereas after the initial sharp decrease little
change occurred over the same period in the concen-
trating capacity of the nontreated group.
a At the time of sacrifice 36 weeks after challenge,
L a the gross pathologic, histopathologic and bacterio-a a logic features of renal infection in the treated and
HA nontreated animals were compared (Fig. 7). Differen-
a a a ces in the degree of damage, assessed histopatholog-
a a ically, were not particularly marked despite the fact
a a that active infection persisted in the untreated group
.9 La over the entire period of the study (P = 0.1 for the
0.1 < a 0.01 < gross and histopathologic assessments). Similar re-
P <0.05 P = 0.8 P = 0.02 P <0.025
I I I suits were found when several prominent features of
6 12 26 36 the histopathology in the treated and nontreated ani-
Weeks after renal infection mals were compared (Table 1).
Cortical lesions did not commonly extend into the
renal parenchyma, and the histopathologic exam-
ination confirmed the gross appearance of extensive
but relatively nonpenetrating scar formation. There
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Fig. 4. Glomerular filtration rates in antibiotic-treated and non-
trea ted pyelonephritic animals over a 36-week period. Antibiotics
were administered daily for ten days, one week and two months
after challenge. The kidneys from the pyelonephritic but treated
animals were sterile (one exception) at autopsy.
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Fig. 6. Urine concentrating capacity in antibiotic-treated and non-
treated pyelonephritic animals.
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Fig. 7. Comparative bacteriology, gross pathology and histopa-
thology of antibiotic-treated and nontreated pyelonephritic animals
at autopsy 36 weeks after the initial challenge. Gross pathology:
Assessment was made on a 0 to 10 scale with each point on the
scale representing one-tenth of the surface of the kidney. Degree of
histopathologic damage: On the scale used, 10 represented lesions
involving 25% or more of the area of the section. Lesser degrees of
damage were scored on a 0 to 10 scale where each unit represented
2.5% of the area of the kidney section.
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Discussion
The effect of pyelonephritis on renal function has
0 been reported by other authors using a variety of
0 experimental models and modes of investigation. Our
objective in these experiments was to study the effect
a ofchronic active E. coli pyelonephritis on renal func-a A tion and to determine the effect of antibiotic treat-
ment and elimination of infection on the gross pathol-
A ogy, histopathology and renal function of animals
A o with chronic pyelonephritis.
The present studies have shown that a marked loss
A 0 of concentrating capacity was demonstrable when the
A maximum urinary osmolality of a group of animals
with unilateral pyelonephritis was compared with
normal control animals. A severe loss of concentrat-
ing capacity occurred during the first month but the
subsequent loss of concentrating capacity over a fur-
ther 30-week period was minimal. A compensatory
increase in the GFR in the control nonchallenged
group occurred after nephrectomy but no com-
parable compensation in the infected group was
found. Blood urea concentrations in the pyelone-
phritic animals were not significantly different from
the unchallenged control groups despite the extent of
the pathological damage in the former group.
Antibiotic therapy had a marked effect on the
was evidence of glomerular crowding, interstitial fi-
brosis and tubular atrophy in both the cortex and
medulla and a lymphocytic infiltrate which was par-
ticularly marked in the renal cortex. Colloid casts
were present in all of the kidneys examined but gb-
merular and vascular abnormalities were not found
apart from areas of scarring where glomerular tufts
were frequently missing from the capsular spaces.
Despite the sometimes extensive involvement of renal
cortical tissue, there was little evidence to suggest that
tissue destruction was progressive. In most cases the
lesions were circumscribed and reflected the extent of
the initial infectious process following the direct in-
oculation of bacteria into the kidney.
The involvement of the medullary and, partic-
ularly, the papillary tissue was of interest. Dilation of
the collecting tubules and interstitial fibrosis were
commonly found in the papilla and in several cases
marked papillary deformation and blunting of the
papillary tip was seen.
Effect of antibiotic administration on renal function.
Antibiotic therapy with gentamicin, a potentially
nephrotoxic drug may have contributed to the slow
decline in the maximum urine concentrating capacity
of the antibiotic-treated group (Fig. 6). To determine
the effect of antibiotic therapy on renal function, two
groups of 12 rats were unilaterally nephrectomised
and one group was treated three weeks later with
gentamicin and carbenicillin. A similar course of
treatment was given two months later to the same
group. When the GFR, blood urea and urinary con-
centrating capacity were followed in both groups
over a 30-week period, no significant differences were
found (Table 2).
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Table 1. Assessment of the effect of antibiotic therapy on several histopathologic features of chronic pyelonephritis
Animals
N
Degree of
renal damages
Mononuclear
infiltrationb
Lesion in the
medulla and
papillac
Colloid
casts"
Pyelonephritis
(treated) 15 4.0 = 1.6 3.3 = 1.3 4.3 = 2.3 3.2 = 2.0
Pyelonephritis
(nontreated) 20 4.73 = 2.1 3.9 = 1.7 5.4 = 2.0 3.3 = 2.2
Wilcoxon analysise NSD NSD NSD NSD
Degree of renal damage: on the scale used, 10 represented lesions involving 25% or more of the area of the section. Lesser degrees of
damage were scored on a 0 to 10 scale where each unit represented 2.5% of the area of the kidney section.
Degree of mononuclear infiltrate: quantitative 0 to 10 scale used to make a comparative assessment of the degree of mononuclear
infiltrate.
Lesions in the medulla and papilla: a comparative 0 to 10 scale was used. Mild, focal, collecting duct hyperplasia and an increase
in connective tissue represented minor changes while extensive fibrosis, tubular dilation with blunting and deformation of the papillary tip
were considered major pathological changes.
" Colloid casts: quantitative scale where each unit was equal to the average number of colloid casts seen per kidney section.
NSD: no significant difference when the two groups were compared by the Wilcoxon sum of ranks analysis for nonparametric data.
urinary concentrating capacity in pyelonephritic ani-
mals and the defect in concentrating ability was signif-
icantly less in the treated animals during the first 30
days after challenge. Infection again prevented a com-
pensatory increase in the GFR of pyelonephritic ani-
mals but this was not reversed by antibiotic therapy.
Blood urea concentrations in treated and nontreated
groups were not significantly different nor did anti-
biotic therapy and the eradication of infection appear
to affect the gross pathologic and histopathologic
changes found at autopsy.
Several other studies of experimental pyelone-
phritis have demonstrated a urinary concentrating
defect with results similar to those reported here.
Kaye and Rocha [8] also observed a concentrating
defect in experimentally induced pyelonephritis but
considered that, as it was readily reversed, it was not
associated with permanent renal damage. Gonick et
al [9] were also able to demonstrate a reduced max-
imal concentrating capacity as early as one week after
the induction of enteroccoccal pyelonephritis al-
though repetitive injections of bacteria were neces-
sary to maintain a depressed concentrating capacity.
One of the most interesting observations was that
treatment of infection with antibiotics limited the de-
gree of depression of concentrating ability during the
initial 30 days after challenge. In related experiments
we have repeatedly shown that the gross pathologic
and histopathologic changes in animals examined 30
days after challenge were not affected by antibiotic
therapy even when treatment commenced as early as
seven days after induction of infection (Miller T,
North D, Burnham S, unpublished data). This
strongly suggests that the severe depression of urine
concentrating capacity was associated with active bac-
terial infection as well as the loss of functional neph-
rons in the pyelonephritic lesions.
Other investigators have also suggested that a loss
of concentrating ability in experimental pyelone-
phritis may be caused by infection alone, Kaye and
Table 2. Effect of gentamicin a nd carbenicillin administration on renal function in unilaterally nephrectomized animals
Weeks after antimicrobial therapy
3 6 12 30
Mean Stat.
signif.
Mean Stat. Mean
signif.
Stat.
signif.
Mean Stat.
signif.
Glomerular
filtration rate,
mi/mm
0.53
(0.46)"
O.07
0.55
(0.52)
0.66
0.6
(0.67)
0.6
0.53
(0.54)
0.8
Blood urea,
mg/lOO ml
71
(73)b
0.7
68
(70)
74
0.65
(77)
0.3
82
(76)
0.15
Maximum urine
concentrating
capacity, mOsm/kg
2336
(2290)"
0.7
2200
(2300)
1900
0.8
(2230)
0.3
2251
(2200)
0.6
Probability determined by Student's t test for difference of means.
Mean of the control group.
Chronic experimental pyelonephrilis 29
Rocha [8] found a poor correlation between histo-
pathologic changes and the maximum urine concen-
trating ability, and Beck et a! [10], in a study of
staphylococcal pyelonephritis, found that resolution
of the lesion was associated with the restoration of
renal function but persistent active infection resulted
in a continued impairment.
Recent experiments documenting acquiescent in-
fection in animal models have also shown that a re-
duction in urinary concentrating capacity may occur
in the absence of associated pathological changes [7]
and there seems to be little doubt that the bacterio-
logic status of the kidney is an important factor deter-
mining the concentrating capacity of the pyelone-
phritic kidney.
The ability of antibiotic therapy to restore urinary
concentrating capacity in individuals with renal in-
fection also suggests that acquiescent infection may
occur in man and provides an explanation for the
efficacy of appropriate therapy in restoring normal
renal function [11, 12]. One factor limiting the appre-
ciation of the significance of infection alone as a de-
terminant affecting renal function has been the belief
that active bacterial infection is confined to regions of
the kidney with evidence of inflammatory changes.
This is almost certainly not the case as we have shown
recently [7] and confirmed in continuing experiments.
Our experiments have shown clearly that the con-
centrating defect had a composite etiology of which
pathologic damage and bacterial infection were indi-
vidual components. The effects of pathologic damage
were not reversible although early treatment with an-
tibiotics could diminish or eliminate the effect of in-
fection alone. Analysis of the pathologic changes in
the pyelonephritic but treated animals at autopsy 36
weeks after the initiation of infection showed that
continued renal infection did not result in a signifi-
cant progression of the pyelonephritic lesion when
the results were compared with untreated pyelone-
phritic animals. The findings are in broad agreement
with those of Glassock, Kalmanson and Guze, who
also found that the events occurring early in infection
determined the eventual functional and histopatho-
logic characteristics of the disease [13].
These results underscore the doubts raised by a
number of workers regarding the role of continued
infection in the etiology of chronic progressive pyelo-
nephritis [14—16]. The high morbidity carried by in-
fections of the urinary tract is unquestioned, yet ter-
minal renal failure from chronic pyelonephritis is not
common despite the frequency of urinary tract in-
fections [17]. Although the host-parasite relationship
in chronic pyelonephritis has been subjected to in-
tensive research, many details remain to be defined
and present the clinical and experimental investigator
with a complex problem.
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